title: Additional factors that could improve cost-effectiveness of pharmacogenetic-guided dosing in warfarin therapy.
authors: Benjamin P
authors: BP
authors: Geisler
authors: Jeffrey K
authors: JK
authors: Levin-Scherz
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000235:genetics*; D003362:Cost-Benefit Analysis; D005838:Genotype; D006801:Humans; D014859:Warfarin / Q000008:administration & dosage*
chemical_list: D000925:Anticoagulants; D014859:Warfarin